In the last trading session, 1.79 million Unicycive Therapeutics Inc (NASDAQ:UNCY) shares changed hands as the company’s beta touched 1.98. With the company’s per share price at $6.8 changed hands at $0.86 or 14.48% during last session, the market valuation stood at $86.82M. UNCY’s last price was a discount, traded about -61.76% off its 52-week high of $11.00. The share price had its 52-week low at $2.02, which suggests the last value was 70.29% up since then. When we look at Unicycive Therapeutics Inc’s average trading volume, we note the 10-day average is 1.22 million shares, with the 3-month average coming to 413.00K.
Analysts gave the Unicycive Therapeutics Inc (UNCY) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended UNCY as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
Unicycive Therapeutics Inc (NASDAQ:UNCY) trade information
Instantly UNCY was in green as seen at the end of in last trading. With action 7.26%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 36.00%, with the 5-day performance at 7.26% in the green. However, in the 30-day time frame, Unicycive Therapeutics Inc (NASDAQ:UNCY) is 11.31% up. Looking at the short shares, we see there were 0.37 million shares sold at short interest cover period of 0.64 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -31.80%. The 2025 estimates are for Unicycive Therapeutics Inc earnings to increase by 74.92%.
UNCY Dividends
Unicycive Therapeutics Inc is expected to release its next quarterly earnings report on 2025-May-14.
Unicycive Therapeutics Inc (NASDAQ:UNCY)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 4.93% of Unicycive Therapeutics Inc shares while 49.60% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 52.17%. There are 49.60% institutions holding the Unicycive Therapeutics Inc stock share, with VIVO CAPITAL, LLC the top institutional holder. As of 2024-06-30, the company held 9.9395% of the shares, roughly 3.47 million UNCY shares worth $1.74 million.
LOGOS GLOBAL MANAGEMENT LP holds the second largest percentage of outstanding shares, with 9.9389% or 3.47 million shares worth $1.74 million as of 2024-06-30.
